MONOCLONAL ANTIBODY AGAINST CXCL13 TO PROMOTE AXONAL PLASTICITY, REGENERATION, AND FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY: A TRANSLATIONAL OPPORTUNITY
$539,979FY2021Department of the ArmyDOD
Imperial College Of Science, Technology And Medicine, London